Research Methods Core

研究方法核心

基本信息

  • 批准号:
    10207339
  • 负责人:
  • 金额:
    $ 20.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-30 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary To achieve the most impact on the HIV epidemic, interventions that address alcohol misuse in the context of HIV prevention and care must be evaluated and implemented with an emphasis on real-world effectiveness, scalability, and sustainability. Consistent with this, the central theme of this segment of support for the Brown University Alcohol Research Center on HIV (ARCH) involves evaluating novel methods of addressing alcohol use in HIV prevention and care contexts both domestically and globally, using technology-delivered interventions, telehealth, and state-of-the-art implementation strategies. The Research Methods Core (RMC) is a shared resource that will support the mutual needs of the ARCH’s constituent research components by providing assistance with (1) data collection, management, synergy, and analysis, (2) technology-assisted assessments and interventions, and (3) implementation science. With contributions from faculty in biostatistics, digital health, and implementation science, as well as experienced data management and programming staff, the RMC will directly support these needs by creating data collection instruments and intervention components, developing participant and data management systems, authoring scripts to compile and harmonize datasets across multiple sources, and facilitate data archiving. RMC personnel will also provide consultation on research design, assessment best-practices, and will lead primary statistical analyses proposed in each project. Finally, RMC personnel will provide ongoing guidance on implementation science methods for each project, compile resources on implementation science frameworks and methods, and offer education and training on implementation science topics. As such, the resources provided by the RMC core will enable the research components to utilize best-practices in the areas of study design and data analysis and ensure that the research they produce is rigorous and achieves the most impact. Providing general support for data management through the RMC can also ensure that consistent approaches are used in each project, that data are harmonized whenever possible, and that data are archived and shared efficiently. It also creates an economy of scale, where data management tasks used in one study can more easily be applied across others, obviating the need for each study to develop and support these methods themselves. Finally, providing a shared resource for training and guidance on implementation science issues will enable each project to utilize best practices in the field and ultimately help advance each toward its goal of integrating and sustaining alcohol interventions in practice settings.
项目摘要 为了对艾滋病毒流行病产生最大影响,应对酗酒问题的干预措施应包括: 艾滋病毒预防和护理的评价和实施必须强调现实世界的有效性, 可扩展性和可持续性。与此相一致的是,这部分支持布朗的中心主题 大学酒精研究中心对艾滋病毒(艾滋病)涉及评估新的方法来解决酒精 使用技术在国内和全球的艾滋病毒预防和护理环境中使用 干预措施、远程保健和最先进的实施战略。研究方法核心(RMC)是 一个共享的资源,将支持共同体的组成研究组成部分的相互需要, 在以下方面提供援助:(1)数据收集、管理、协同和分析;(2)技术辅助 评估和干预,以及(3)实施科学。在生物统计学教师的贡献下, 数字健康和实施科学,以及经验丰富的数据管理和编程人员, RMC将通过创建数据收集工具和干预组件直接支持这些需求, 开发参与者和数据管理系统,编写脚本以汇编和统一数据集 跨多个来源,并促进数据归档。RMC人员还将提供以下咨询: 研究设计,评估最佳做法,并将导致在每个主要统计分析提出 项目最后,RMC人员将为每个项目的实施科学方法提供持续的指导。 项目,汇编关于实施科学框架和方法的资源,并提供教育和 关于执行科学专题的培训。因此,RMC核心提供的资源将使 研究部分利用研究设计和数据分析领域的最佳做法,并确保 他们所做的研究是严格的,并取得了最大的影响。为数据提供一般支持 通过风险管理委员会的管理还可以确保在每个项目中使用一致的方法, 在可能的情况下进行协调,并有效地存档和共享数据。它还创建了一个 规模经济,一项研究中使用的数据管理任务可以更容易地应用于其他研究, 避免了每个研究本身开发和支持这些方法的需要。最后,提供一个 关于执行科学问题的培训和指导的共享资源将使每个项目能够利用 在该领域的最佳做法,并最终帮助推进其整合和维持酒精的目标 在实践环境中的干预。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tao Liu其他文献

Tao Liu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tao Liu', 18)}}的其他基金

Center for Advanced Multi-Omic Characterization of Cancer
癌症高级多组学表征中心
  • 批准号:
    10439370
  • 财政年份:
    2022
  • 资助金额:
    $ 20.32万
  • 项目类别:
Center for Advanced Multi-Omic Characterization of Cancer
癌症高级多组学表征中心
  • 批准号:
    10631927
  • 财政年份:
    2022
  • 资助金额:
    $ 20.32万
  • 项目类别:
Center for Advanced Multi-Omic Characterization of Cancer
癌症高级多组学表征中心
  • 批准号:
    10755578
  • 财政年份:
    2022
  • 资助金额:
    $ 20.32万
  • 项目类别:
Targeted therapy against TERT oncogene-rearranged neuroblastoma
TERT癌基因重排神经母细胞瘤的靶向治疗
  • 批准号:
    10452641
  • 财政年份:
    2021
  • 资助金额:
    $ 20.32万
  • 项目类别:
Targeted therapy against TERT oncogene-rearranged neuroblastoma
TERT癌基因重排神经母细胞瘤的靶向治疗
  • 批准号:
    10287498
  • 财政年份:
    2021
  • 资助金额:
    $ 20.32万
  • 项目类别:
PNNL Proteome Characterization Center
PNNL 蛋白质组表征中心
  • 批准号:
    9210313
  • 财政年份:
    2016
  • 资助金额:
    $ 20.32万
  • 项目类别:
PNNL Proteome Characterization Center
PNNL 蛋白质组表征中心
  • 批准号:
    9356484
  • 财政年份:
    2016
  • 资助金额:
    $ 20.32万
  • 项目类别:
PNNL Proteome Characterization Center
PNNL 蛋白质组表征中心
  • 批准号:
    9754797
  • 财政年份:
    2016
  • 资助金额:
    $ 20.32万
  • 项目类别:
Research Methods Core
研究方法核心
  • 批准号:
    10413170
  • 财政年份:
    2010
  • 资助金额:
    $ 20.32万
  • 项目类别:
Research Methods Core
研究方法核心
  • 批准号:
    10650186
  • 财政年份:
    2010
  • 资助金额:
    $ 20.32万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了